Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Appyea Inc APYP

AppYea, Inc. is a digital health company, which is focused on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring and fundamentally improve quality of life. The Company’s business plan focuses on two principal devices and an App in development: DreamIT and DreamIT PRO, and SleepX PRO. DreamIT is a biofeedback snoring treatment wristband, combined with the... see more

Recent & Breaking News (OTCQB:APYP)

AppYea Launches E-Commerce Store on Amazon Broadening Distribution

Accesswire March 20, 2024

AppYea Enters Commercial Phase with First Deliveries of AppySleep to Customers in the U.S.

Accesswire January 10, 2024

AppYea Provides Year-End Letter to Shareholders Recapping Key Achievements and Sharing Outlook for 2024

Accesswire December 13, 2023

AppYea Secures US Patent for Innovative Sleep Apnea Detection Using Speech Analysis

Accesswire August 28, 2023

AppYea Announces Equity Financing Transaction to Accelerate Commercial Launch

Accesswire August 3, 2023

AppYea Announces Appointment of Leading Medical Device Industry Executive Adi Shemer as CEO

Accesswire July 31, 2023

Leading Operations Executive Adi Shemer Joins AppYea's Advisory Board

Accesswire February 16, 2023

Ron Mekler Joins AppYea's Board of Directors Audit Committee Chair

Accesswire January 23, 2023

SleepX has Started Marketing its Flagship Product, DreamIT - an AI-Based Wristband to Treat the Snoring Problem Through Biofeedback

Accesswire November 29, 2022

AppYea, Inc. Engages Smalltell, a Social Commerce and Design Company

GlobeNewswire February 21, 2019

AppYea, Inc. Fulfills First CBD Purchase Order

GlobeNewswire February 19, 2019

AppYea, Inc. Signs Exclusive CBD Infused Beverage Licensing Agreement

GlobeNewswire February 14, 2019

AppYea, Inc. Enters into CBD Distribution Agreement

GlobeNewswire February 6, 2019

AppYea, Inc. Enters into Management Agreement with Hempori, Inc.

GlobeNewswire January 29, 2019

AppYea Signs Sales and Marketing Agreement with Syncier BioTech

Marketwired November 28, 2017

AppYea's Subsidiary The Diagnostic Centers Signs First New Client

Marketwired November 2, 2017

AppYea Launches Three New Apps on Google Play

Marketwired October 17, 2017

AppYea Announces Sales and Marketing Team for Its Diagnostic Centers Inc.

Marketwired September 20, 2017

AppYea Announces New Diagnostic Division

Marketwired August 17, 2017

AppYea Falls Victim to Elaborate Fraud

Marketwired April 28, 2016